COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 89: Articles 881-890  | Next

Tuberculosis services delivery challenges and their mitigations during the COVID-19 pandemic in Tanzania: A qualitative study
Pamba, D., Sanga, E., William, W., Mvungi, H., Omary, H., Setebe, T., Olomi, W., Mangu, C., Sabi, I., Balama, R., Matechi, E., Kisonga, R., Tarimo, A., Ntinginya, N. E., Maganga, L.
10.1101/2025.03.19.25324251 — Posted: 2025-03-20
Inequalities in NHS Staff Support among those from Ethnic Minority and Migrant groups during the COVID-19 Pandemic.
Croak, B., Lamb, D., Stevelink, S., Bhundia, R., Onwumere, J., Dempsey, B., Almeida-Meza, P., Chui, Z., Greenberg, N., Raine, R., Woodhead, C., Hatch, S., Rhead, R.
10.1101/2025.03.19.25324242 — Posted: 2025-03-20
Turning Challenges into Opportunities: Lessons from Ethiopias COVID-19 Response for Strengthening Health Systems and Health Security
Mossie, M. Y., Shannon, J., Desta, A. B., Brhanesilassie, E., Dufera, A., Nawaz, S.
10.1101/2025.03.17.25324158 — Posted: 2025-03-19
Capturing SARS-CoV-2 immune landscapes to inform future strategies for COVID-19 vaccination in a high-income setting: a mathematical modelling study
Hogan, A. B., Muscatello, D. J., Liu, B., Nedjati-Gilani, G., Wood, J. G.
10.1101/2025.03.18.25324222 — Posted: 2025-03-19
Wearable heart rate variability monitoring identifies autonomic dysfunction and thresholds for post-exertional malaise in Long COVID
Ruijgt, T., Slaghekke, A., Ellens, A., Janssen, K., Wust, R. C.
10.1101/2025.03.18.25320115 — Posted: 2025-03-19
Effect of the COVID-19 pandemic on drug-resistant tuberculosis treatment outcomes at a national referral hospital in Sierra Leone, 2017 to 2022: a retrospective study
Koroma, J. A., Mahmoud, M., Molleh, B., Sevalie, S., Chan, A. K., Mishra, S., Lakoh, S., Kanu, J. S.
10.1101/2025.03.17.25324153 — Posted: 2025-03-19
Machine Learning Reveals Distinct Immunogenic Signatures of Th1 Imprinting in ART-Treated Individuals with HIV Following Repeated SARS-CoV-2 Vaccination
Korosec, C. S., Conway, J. M., Matveev, V. A., Ostrowski, M., Heffernan, J. M., Ghaemi, M. S.
10.1101/2025.03.18.643769 — Posted: 2025-03-19
Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate
Srivastava, S., Kumar, S., Mishra, S., Rajmani, R. S., Singh, R., Dutta, S., Ringe, R. P., Varadarajan, R.
10.1101/2025.03.17.643667 — Posted: 2025-03-18
Cytokine storm polymorphisms in nonvaccinated COVID-19 patients
Martinez-Gomez, L. E., Oropeza-Velez, C. I., Almonte-Becerril, M., Chavez-Galan, L., Martinez-Armenta, C., Vidal-Vazquez, R. P., Ramirez-Hinojosa, J. P., Vazquez-Cardenas, P., Gomez-Martin, D., Vargas-Alarcon, G., Rodriguez-Perez, J. M., Ramon-Luing, L. A., Flores-Gonzalez, J., Carrasco, J. G., Mata-Miranda, M. M., Vazquez-Zapien, G. J., Martinez-Cuazitl, A., Parra-Torres, N., Martinez-Ruiz, F., Zayago-Angeles, D. M., Ordonez-Sanchez, M. L., Segura-Kato, Y., Suarez-Ahedo, C., Olea-Torres, J., Herrera-Lopez, B., Pineda, C., Martinez-Nava, G. A., Lopez-Reyes, A.
10.1101/2025.03.14.25323971 — Posted: 2025-03-17
Incidence of community acquired lower respiratory tract disease in Bristol, UK following the emergence of SARS-CoV-2: a prospective cohort study 2020-2024
Chatzilena, A., Hyams, C., Challen, R., Begier, E., Southern, J., Lahuerta, M., McGuinness, S., Clout, M., Campling, J., Oliver, J., Vyse, A., Ellsbury, G., Maskell, N., Gessner, B., Finn, A., Danon, L., The Avon CAP Research Group
10.1101/2025.03.17.25324087 — Posted: 2025-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).